Autres langues Vivesto AB

Actions

VIVE

SE0000722365

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:29:32 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,306 ^SEK	+4,26 %		+7,37 %	-24,91 %

26/03	Transcript : Vivesto AB - Special Call
07/03	Vivesto AB administre le premier patient de son essai clinique Paccal Vet	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Notice of Annual General Meeting in Vivesto AB	23/04
Vivesto to hold live-streamed Paccal Vet R&D Update on March 26	19/03
Vivesto doses first patient in its clinical Paccal Vet trial	07/03
Vivesto AB Doses First Patient in its Clinical Paccal Vet Trial	07/03
Vivesto AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Vivesto's international patent application for XR-18 receives positive decision	30/01
Vivesto's International Patent Application for XR-18 Receives Positive Decision	30/01
Vivesto Gains on Receipt of US Approval for Pilot Clinical Trial of Drug Candidate Paccal Vet	28/12
Vivesto’s US clinical Paccal Vet trial receives approval to start patient recruitment	28/12
Vivesto AB's US Clinical Paccal Vet Trial Receives Approval to Start Patient Recruitment	28/12
Vivesto’s Paccal Vet granted FDA MUMS designation	22/12
Vivesto makes impairment charge following withdrawal of European market authorizations for Apealea	22/12
Vivesto AB Reports Positive Preclinical Data Supporting Continued Development of Cantrixil	19/12
Vivesto reports positive preclinical data supporting continued development of Cantrixil	19/12
Nomination Committee appointed for the 2024 Annual General Meeting in Vivesto	23/11
Vivesto AB Announces Composition of Nomination Committee	23/11
Vivesto Abandons Apealea Partnership with Elevar Therapeutics	23/11
Vivesto and Elevar sign agreement ending Apealea® partnership	23/11
Vivesto AB and Elevar Therapeutics Inc. Sign Agreement Ending Apealea®? Partnership	23/11
Interim report for the period January 1, 2023 – September 30, 2023	16/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Vivesto AB

Actions

VIVE

SE0000722365

Autres langues

Filtres